Regeneron Pharmaceuticals
Regeneron is seeking 2027 Co-ops to join the Product Biochemistry team in Tarrytown, NY, for full-time, onsite positions spanning Spring-Summer, Summer-Fall, or Fall terms. These roles provide an opportunity to contribute to a science-driven organization developing life-changing medicines for serious diseases. Co-ops will work with analytical and biophysical characterization methods to understand the structure, stability, and function of biologic and oligonucleotide-based medicines.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Principal Scientist
Synolo Therapeutics
Associate Principle Scientist
lifelancer
Scientist, Quantitative Biochemistry
Voyager Therapeutics
Sr. Scientist, Preclinical Dev.
Merck & Co., Inc.
Scientist, AI/ML — Antibody Developability
Ginkgo Bioworks
Biologics Formulation Research Internship
Varda Space Industries